Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYEli Lilly and Company | 755.34 B USD | 795.67 USD | −0.08% | 1.17 M | 0.29 | 87.04 | 9.14 USD | +68.74% | 0.65% | Health technology | Buy |
NVONovo Nordisk A/S DR | 384.03 B USD | 87.37 USD | −1.51% | 4.77 M | 0.42 | 28.33 | 3.08 USD | +28.16% | 1.16% | Health technology | Buy |
JNJJohnson & Johnson | 351.15 B USD | 145.85 USD | +0.40% | 3.16 M | 0.31 | 24.11 | 6.05 USD | +15.46% | 3.38% | Health technology | Buy |
ABBVAbbVie Inc. | 318.09 B USD | 180.00 USD | +0.90% | 2.69 M | 0.35 | 62.77 | 2.87 USD | −21.52% | 3.48% | Health technology | Buy |
MRKMerck & Company, Inc. | 251.57 B USD | 99.45 USD | +0.08% | 3.71 M | 0.26 | 20.83 | 4.77 USD | +165.21% | 3.10% | Health technology | Buy |
AZNAstraZeneca PLC DR | 202.48 B USD | 66.30 USD | −0.50% | 2.15 M | 0.34 | 31.86 | 2.08 USD | +10.04% | 2.18% | Health technology | Buy |
NVSNovartis AG DR | 193.15 B USD | 98.35 USD | −0.10% | 337.38 K | 0.29 | 11.47 | 8.57 USD | +130.62% | 3.25% | Health technology | Neutral |
PFEPfizer, Inc. | 151.54 B USD | 26.74 USD | +0.11% | 19.72 M | 0.39 | 35.95 | 0.74 USD | −59.14% | 6.29% | Health technology | Buy |
SNYSanofi DR | 119.81 B USD | 48.29 USD | −0.21% | 1.64 M | 0.54 | 26.62 | 1.81 USD | −49.14% | 3.05% | Health technology | Buy |
BMYBristol-Myers Squibb Company | 117.15 B USD | 57.76 USD | +0.31% | 3.67 M | 0.24 | — | −3.60 USD | −191.22% | 4.17% | Health technology | Neutral |
VRTXVertex Pharmaceuticals Incorporated | 105.12 B USD | 408.18 USD | +0.72% | 1.47 M | 0.58 | — | −1.99 USD | −114.96% | 0.00% | Health technology | Buy |
REGNRegeneron Pharmaceuticals, Inc. | 78.51 B USD | 714.47 USD | −0.09% | 382.14 K | 0.37 | 17.68 | 40.41 USD | +15.25% | 0.00% | Health technology | Buy |
ZTSZoetis Inc. | 74.31 B USD | 164.70 USD | +0.26% | 1.02 M | 0.38 | 30.97 | 5.32 USD | +8.17% | 1.05% | Health technology | Buy |
GSKGSK plc DR | 68.22 B USD | 34.03 USD | −0.09% | 1.38 M | 0.33 | 22.14 | 1.54 USD | −57.75% | 4.52% | Health technology | Neutral |
TAKTakeda Pharmaceutical Company Limited DR | 41.56 B USD | 13.17 USD | 0.00% | 968.36 K | 0.58 | 21.84 | 0.60 USD | +36.22% | 4.81% | Health technology | Buy |
ALNYAlnylam Pharmaceuticals, Inc. | 31.37 B USD | 243.25 USD | +0.41% | 253.07 K | 0.34 | — | −2.62 USD | +36.82% | 0.00% | Health technology | Buy |
BIIBBiogen Inc. | 21.72 B USD | 149.02 USD | −0.24% | 524.89 K | 0.27 | 13.46 | 11.07 USD | +10.06% | 0.00% | Health technology | Buy |
BGNEBeiGene, Ltd. DR | 19.86 B USD | 181.62 USD | +2.21% | 148.37 K | 0.30 | — | −8.24 USD | +11.11% | 0.00% | Health technology | Strong buy |
UTHRUnited Therapeutics Corporation | 16.11 B USD | 360.87 USD | −0.76% | 138.36 K | 0.36 | 15.85 | 22.77 USD | +25.44% | 0.00% | Health technology | Buy |
RPRXRoyalty Pharma plc | 14.87 B USD | 25.23 USD | −0.08% | 1.35 M | 0.34 | 9.87 | 2.56 USD | +538.81% | 3.33% | Health technology | Strong buy |
VTRSViatris Inc. | 14.8 B USD | 12.40 USD | −0.72% | 4.06 M | 0.31 | — | −0.74 USD | −148.99% | 3.84% | Health technology | Neutral |
NBIXNeurocrine Biosciences, Inc. | 13.82 B USD | 136.53 USD | −0.34% | 341.45 K | 0.27 | 36.58 | 3.73 USD | +99.71% | 0.00% | Health technology | Strong buy |
GMABGenmab A/S DR | 13.61 B USD | 20.47 USD | −1.40% | 454.76 K | 0.36 | 19.72 | 1.04 USD | +10.05% | 0.00% | Health technology | Buy |
INCYIncyte Corporation | 13.47 B USD | 69.91 USD | +0.10% | 395.9 K | 0.16 | 495.11 | 0.14 USD | −92.50% | 0.00% | Health technology | Buy |
RDYDr. Reddy's Laboratories Ltd DR | 13.13 B USD | 15.67 USD | +1.16% | 1.33 M | 0.83 | 20.43 | 0.77 USD | +3.36% | 0.52% | Health technology | Neutral |
INSMInsmed Incorporated | 12.62 B USD | 70.53 USD | −0.08% | 383.09 K | 0.17 | — | −5.56 USD | −5.41% | 0.00% | Health technology | Strong buy |
SRPTSarepta Therapeutics, Inc. | 11.64 B USD | 121.90 USD | +1.03% | 204.86 K | 0.25 | 101.26 | 1.20 USD | — | 0.00% | Health technology | Strong buy |
EXELExelixis, Inc. | 9.66 B USD | 33.82 USD | +1.02% | 799.46 K | 0.32 | 21.55 | 1.57 USD | +459.23% | 0.00% | Health technology | Buy |
ITCIIntra-Cellular Therapies Inc. | 9.04 B USD | 85.24 USD | +1.48% | 187.2 K | 0.33 | — | −0.86 USD | +47.14% | 0.00% | Health technology | Strong buy |
ROIVRoivant Sciences Ltd. | 8.74 B USD | 12.00 USD | +0.25% | 1.4 M | 0.23 | 2.12 | 5.66 USD | — | 0.00% | Health technology | Strong buy |
ASNDAscendis Pharma A/S DR | 8.35 B USD | 138.79 USD | −0.65% | 72.15 K | 0.16 | — | −8.10 USD | +28.89% | 0.00% | Health technology | Strong buy |
RGENRepligen Corporation | 8.23 B USD | 146.95 USD | +0.89% | 176.07 K | 0.30 | — | −0.15 USD | −108.32% | 0.00% | Health technology | Buy |
JAZZJazz Pharmaceuticals plc | 7.48 B USD | 123.73 USD | −0.42% | 187.95 K | 0.24 | 17.82 | 6.94 USD | +1,051.97% | 0.00% | Health technology | Strong buy |
MDGLMadrigal Pharmaceuticals, Inc. | 6.8 B USD | 312.00 USD | +0.36% | 108.17 K | 0.30 | — | −25.07 USD | −30.31% | 0.00% | Health technology | Strong buy |
LEGNLegend Biotech Corporation DR | 6.22 B USD | 32.80 USD | −3.33% | 890.3 K | 0.53 | — | −1.91 USD | +35.99% | 0.00% | Health technology | Strong buy |
GRFSGrifols, S.A. DR | 5.93 B USD | 7.82 USD | +1.82% | 275.69 K | 0.27 | — | — | — | 0.00% | Health technology | Neutral |
IONSIonis Pharmaceuticals, Inc. | 5.77 B USD | 36.53 USD | +1.25% | 502.73 K | 0.27 | — | −2.44 USD | +14.63% | 0.00% | Health technology | Buy |
CYTKCytokinetics, Incorporated | 5.73 B USD | 48.53 USD | −0.86% | 318.99 K | 0.23 | — | −5.39 USD | +2.40% | 0.00% | Health technology | Buy |
CORTCorcept Therapeutics Incorporated | 5.47 B USD | 52.17 USD | +2.50% | 261.08 K | 0.26 | 41.49 | 1.26 USD | +55.35% | 0.00% | Health technology | Strong buy |
TGTXTG Therapeutics, Inc. | 5.01 B USD | 32.16 USD | −0.31% | 496.46 K | 0.21 | — | −0.11 USD | +60.71% | 0.00% | Health technology | Strong buy |
CRNXCrinetics Pharmaceuticals, Inc. | 5 B USD | 53.94 USD | −0.04% | 150.33 K | 0.16 | — | −3.72 USD | −2.14% | 0.00% | Health technology | Strong buy |
ALKSAlkermes plc | 4.8 B USD | 29.65 USD | +0.51% | 417.11 K | 0.20 | 15.10 | 1.96 USD | +59.05% | 0.00% | Health technology | Buy |
VKTXViking Therapeutics, Inc. | 4.72 B USD | 42.35 USD | +0.07% | 1.06 M | 0.23 | — | −0.94 USD | −1.31% | 0.00% | Health technology | Strong buy |
APLSApellis Pharmaceuticals, Inc. | 4.14 B USD | 33.32 USD | +0.33% | 437.76 K | 0.15 | — | −2.04 USD | +61.20% | 0.00% | Health technology | Buy |
RAREUltragenyx Pharmaceutical Inc. | 4.04 B USD | 43.75 USD | −0.27% | 277.95 K | 0.29 | — | −6.46 USD | +28.02% | 0.00% | Health technology | Strong buy |
PBHPrestige Consumer Healthcare Inc. | 3.89 B USD | 78.75 USD | +0.24% | 90.7 K | 0.30 | 19.18 | 4.11 USD | — | 0.00% | Health technology | Buy |
OGNOrganon & Co. | 3.79 B USD | 14.73 USD | +0.20% | 1.14 M | 0.17 | 2.92 | 5.04 USD | +120.60% | 7.62% | Health technology | Neutral |
VRNAVerona Pharma plc DR | 3.71 B USD | 45.04 USD | −0.53% | 258.74 K | 0.31 | — | −1.94 USD | −197.56% | 0.00% | Health technology | Strong buy |
BHVNBiohaven Ltd. | 3.62 B USD | 35.75 USD | −1.11% | 451.05 K | 0.31 | — | −9.35 USD | −37.39% | 0.00% | Health technology | Strong buy |
PRGOPerrigo Company plc | 3.5 B USD | 25.64 USD | −0.08% | 499.12 K | 0.38 | — | −1.11 USD | −34,712.50% | 4.30% | Health technology | Strong buy |
PTCTPTC Therapeutics, Inc. | 3.5 B USD | 45.35 USD | −0.46% | 185.83 K | 0.27 | — | −5.94 USD | +31.43% | 0.00% | Health technology | Buy |
MLTXMoonLake Immunotherapeutics | 3.37 B USD | 52.67 USD | +1.02% | 123.74 K | 0.54 | — | −1.29 USD | −36.77% | 0.00% | Health technology | Strong buy |
XENEXenon Pharmaceuticals Inc. | 2.93 B USD | 38.42 USD | +0.73% | 129.4 K | 0.28 | — | −2.81 USD | −5.62% | 0.00% | Health technology | Strong buy |
FOLDAmicus Therapeutics, Inc. | 2.93 B USD | 9.79 USD | −0.51% | 921.06 K | 0.34 | — | −0.35 USD | +41.95% | 0.00% | Health technology | Strong buy |
ACADACADIA Pharmaceuticals Inc. | 2.84 B USD | 17.07 USD | −0.58% | 318.19 K | 0.16 | 22.10 | 0.77 USD | — | 0.00% | Health technology | Buy |
VCELVericel Corporation | 2.83 B USD | 57.31 USD | +0.47% | 102.14 K | 0.26 | 916.96 | 0.06 USD | — | 0.00% | Health technology | Strong buy |
NAMSNewAmsterdam Pharma Company N.V. | 2.77 B USD | 25.95 USD | +1.25% | 170.03 K | 0.08 | — | — | — | 0.00% | Health technology | Strong buy |
CPRXCatalyst Pharmaceuticals, Inc. | 2.58 B USD | 21.62 USD | +0.09% | 247.35 K | 0.26 | 18.45 | 1.17 USD | +122.28% | 0.00% | Health technology | Strong buy |
HCMHUTCHMED (China) Limited DR | 2.5 B USD | 14.30 USD | +0.35% | 12.54 K | 0.16 | — | −0.25 USD | −16.10% | 0.00% | Health technology | Strong buy |
AMRXAmneal Pharmaceuticals, Inc. | 2.43 B USD | 7.85 USD | +0.77% | 353.79 K | 0.35 | — | −0.68 USD | −1,181.67% | 0.00% | Health technology | Buy |
CNTACentessa Pharmaceuticals plc DR | 2.31 B USD | 16.90 USD | −3.59% | 193.91 K | 0.25 | — | −1.53 USD | +7.72% | 0.00% | Health technology | Strong buy |
IDYAIDEAYA Biosciences, Inc. | 2.19 B USD | 25.30 USD | −0.32% | 1.45 M | 1.50 | — | −2.33 USD | −19.54% | 0.00% | Health technology | Strong buy |
LGNDLigand Pharmaceuticals Incorporated | 2.14 B USD | 113.38 USD | −0.37% | 58.75 K | 0.37 | 45.11 | 2.51 USD | +200.39% | 0.00% | Health technology | Strong buy |
TARSTarsus Pharmaceuticals, Inc. | 2.07 B USD | 54.04 USD | −0.68% | 128.79 K | 0.20 | — | −3.81 USD | +0.54% | 0.00% | Health technology | Strong buy |
MIRMMirum Pharmaceuticals, Inc. | 2.02 B USD | 42.17 USD | +1.05% | 77.97 K | 0.15 | — | −2.07 USD | +52.00% | 0.00% | Health technology | Strong buy |
AKROAkero Therapeutics, Inc. | 1.99 B USD | 28.56 USD | +0.67% | 266.38 K | 0.37 | — | −3.75 USD | −59.03% | 0.00% | Health technology | Strong buy |
SUPNSupernus Pharmaceuticals, Inc. | 1.97 B USD | 35.60 USD | +0.03% | 125.3 K | 0.31 | 33.33 | 1.07 USD | +175.07% | 0.00% | Health technology | Buy |
AGIOAgios Pharmaceuticals, Inc. | 1.95 B USD | 34.19 USD | −3.28% | 386.49 K | 0.26 | 3.01 | 11.37 USD | — | 0.00% | Health technology | Buy |
HRMYHarmony Biosciences Holdings, Inc. | 1.94 B USD | 34.06 USD | −2.55% | 191.27 K | 0.26 | 16.12 | 2.11 USD | −14.38% | 0.00% | Health technology | Strong buy |
BLTEBelite Bio, Inc DR | 1.94 B USD | 62.00 USD | −1.31% | 35.23 K | 0.87 | — | −1.11 USD | — | 0.00% | Health technology | Strong buy |
SLNOSoleno Therapeutics, Inc. | 1.93 B USD | 44.77 USD | −0.39% | 223.89 K | 0.32 | — | −3.31 USD | −2.66% | 0.00% | Health technology | Strong buy |
IBRXImmunityBio, Inc. | 1.92 B USD | 2.63 USD | −1.50% | 2.02 M | 0.22 | — | −0.89 USD | +15.29% | 0.00% | Health technology | Buy |
MNKDMannKind Corporation | 1.86 B USD | 6.74 USD | −3.99% | 1.41 M | 0.39 | 95.87 | 0.07 USD | — | 0.00% | Health technology | Strong buy |
AMPHAmphastar Pharmaceuticals, Inc. | 1.84 B USD | 38.27 USD | −2.17% | 305.17 K | 0.38 | 12.73 | 3.01 USD | +17.33% | 0.00% | Health technology | Buy |
ARQTArcutis Biotherapeutics, Inc. | 1.75 B USD | 14.99 USD | +0.13% | 1.27 M | 0.47 | — | −1.79 USD | +59.00% | 0.00% | Health technology | Strong buy |
NMRANeumora Therapeutics, Inc. | 1.72 B USD | 10.63 USD | −4.41% | 524.69 K | 0.56 | — | −1.85 USD | −80.83% | 0.00% | Health technology | Strong buy |
EVOEvotec SE DR | 1.55 B USD | 5.00 USD | +12.11% | 279.79 K | 0.91 | — | −0.52 USD | +5.42% | 0.00% | Health technology | Buy |
VRDNViridian Therapeutics, Inc. | 1.53 B USD | 19.31 USD | −1.83% | 466.13 K | 0.18 | — | −4.31 USD | +15.56% | 0.00% | Health technology | Strong buy |
INDVIndivior PLC | 1.5 B USD | 11.99 USD | +0.76% | 1.09 M | 0.77 | — | −0.04 USD | +97.57% | 0.00% | Health technology | Strong buy |
TVTXTravere Therapeutics, Inc. | 1.49 B USD | 17.13 USD | −0.12% | 538.44 K | 0.33 | — | −4.56 USD | −3.48% | 0.00% | Health technology | Strong buy |
PRAXPraxis Precision Medicines, Inc. | 1.44 B USD | 77.25 USD | −0.41% | 100.63 K | 0.20 | — | −10.30 USD | +69.41% | 0.00% | Health technology | Strong buy |
KNSAKiniksa Pharmaceuticals, Ltd. | 1.44 B USD | 19.94 USD | −1.53% | 73.9 K | 0.22 | — | −0.14 USD | −32.91% | 0.00% | Health technology | Strong buy |
NRIXNurix Therapeutics, Inc. | 1.39 B USD | 19.57 USD | −2.05% | 351.44 K | 0.32 | — | −2.91 USD | −5.94% | 0.00% | Health technology | Strong buy |
OCULOcular Therapeutix, Inc. | 1.31 B USD | 8.33 USD | −2.69% | 487.85 K | 0.61 | — | −1.32 USD | −18.71% | 0.00% | Health technology | Strong buy |
DAWNDay One Biopharmaceuticals, Inc. | 1.28 B USD | 12.67 USD | −0.16% | 210.04 K | 0.20 | — | −1.01 USD | +55.62% | 0.00% | Health technology | Strong buy |
HROWHarrow, Inc. | 1.2 B USD | 33.83 USD | −0.53% | 133.62 K | 0.38 | — | −0.94 USD | −108.90% | 0.00% | Health technology | Strong buy |
SEPNSepterna, Inc. | 1.15 B USD | 25.90 USD | −4.39% | 148.09 K | 0.19 | — | — | — | 0.00% | Health technology | Strong buy |
INVAInnoviva, Inc. | 1.11 B USD | 17.78 USD | −0.06% | 205.43 K | 0.25 | 25.85 | 0.69 USD | +55.68% | 0.00% | Health technology | Buy |
SPRYARS Pharmaceuticals, Inc. | 1.11 B USD | 11.41 USD | +1.88% | 497.58 K | 0.35 | — | −0.51 USD | +79.10% | 0.00% | Health technology | Strong buy |
ARDXArdelyx, Inc. | 1.1 B USD | 4.64 USD | +1.31% | 3.22 M | 0.72 | — | −0.31 USD | −149.72% | 0.00% | Health technology | Strong buy |
BBCAXBicara Therapeutics Inc. | 1.04 B USD | 19.12 USD | +1.97% | 227.95 K | 0.26 | — | — | — | 0.00% | Health technology | Strong buy |
GYREGyre Therapeutics, Inc. | 1.02 B USD | 11.90 USD | −2.46% | 50.61 K | 0.35 | — | — | — | 0.00% | Health technology | — |
PHVSPharvaris N.V. | 1.02 B USD | 18.83 USD | −0.53% | 12.6 K | 0.22 | — | −2.68 USD | +16.70% | 0.00% | Health technology | Strong buy |
AVDLAvadel Pharmaceuticals plc | 985.78 M USD | 10.23 USD | +0.89% | 279.32 K | 0.25 | — | −0.77 USD | +64.19% | 0.00% | Health technology | Strong buy |
ZYMEZymeworks Inc. | 982 M USD | 14.14 USD | −0.98% | 208.99 K | 0.32 | — | −1.51 USD | −148.37% | 0.00% | Health technology | Buy |
LQDALiquidia Corporation | 975.86 M USD | 11.53 USD | +0.79% | 341.02 K | 0.39 | — | −1.62 USD | −82.56% | 0.00% | Health technology | Strong buy |
COLLCollegium Pharmaceutical, Inc. | 937.19 M USD | 29.06 USD | −0.31% | 121.12 K | 0.21 | 12.54 | 2.32 USD | +1,442.05% | 0.00% | Health technology | Buy |
ETNB89bio, Inc. | 933.6 M USD | 7.94 USD | −0.63% | 379.62 K | 0.22 | — | −2.91 USD | −45.57% | 0.00% | Health technology | Buy |
PCRXPacira BioSciences, Inc. | 898.99 M USD | 19.47 USD | +1.41% | 269.95 K | 0.27 | — | −2.05 USD | −2,733.63% | 0.00% | Health technology | Neutral |
AVBPArriVent BioPharma, Inc. | 897.36 M USD | 26.63 USD | +2.31% | 73.61 K | 0.40 | — | −2.42 USD | −38.12% | 0.00% | Health technology | Strong buy |